Quantitative Measurement of the Direct Public Health Impact of Medicines Withdrawals in Europe: Development of a Modelling Method and Proof‐of‐Concept Study to Estimate the Morbidity and Mortality Prevented by Regulatory Action
This model quantifies the public health impact of MA withdrawal and revocation in terms of serious morbidity, resulting from eliminated or reduced usage of medicines. This method can be applied to products in other settings to quantify the impact of other pharmacovigilance actions.
Authors
- Saad Shakir (ORCID: https://orcid.org/0000-0002-4084-297X)
- Elizabeth Lynn (ORCID: https://orcid.org/0000-0002-3905-1046)
- Samantha Lane (ORCID: https://orcid.org/0000-0001-7532-1149)
Institutions
- Drug Safety Research Unit (GB)
- University of Portsmouth (GB)
Publication Details
- Journal
- Pharmacoepidemiology and Drug Safety
- Published
- 2024-08-30
- DOI
- https://doi.org/10.1002/pds.70003
- Citations
- 1
- Primary Topic
- Health Systems, Economic Evaluations, Quality of Life
- Type
- article
- Field-Weighted Citation Impact
- 1.13